Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations

MENLO PARK, Calif.: MENLO PARK, Calif., June 14, 2021 /PRNewswire/ -- Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced the appointment of Terry Pizzie as Chief Executive Officer (CEO) of operating company Astrea Bioseparations. Pizzie succeeds Dr. Steve Burton, who will remain with the...

Click to view original post